Dataset Information

Magnetic Nanoparticle-Reduced Graphene Oxide Nanocomposite as a Novel Bioelectrode for Mediatorless-Membraneless Glucose Enzymatic Biofuel Cells.

ABSTRACT: In this work, an enzymatic biofuel cell (EBC) based on a membraneless and mediatorless glucose enzymatic fuel cell system was constructed for operation in physiological conditions (pH 7.0 and temperature 37?°C). The new platform EBC made of nanocomposite, including magnetic nanoparticles (Fe3O4 NPs) and reduced graphene oxide (RGO), was used for the immobilization of glucose oxidase (GOD) as bioanode and bilirubin oxidase (BOD) as biocathode. The EBC bioelectrodes were fabricated without binder or adhesive agents for immobilized enzyme and the first EBC using superparamagnetic properties with Fe3O4 NPs has been reported. The performance of the EBC was evaluated with promising results. In EBC tests, the maximum power density of the EBC was 73.7??W?cm-2 and an open circuit voltage (OCV) as +0.63?V with 5?mM of glucose concentration for the physiological condition of humans. The Fe3O4-RGO nanocomposite offers remarkable enhancement in large surface areas, is a favorable environment for enzyme immobilization, and facilitates electron transfer between enzymes and electrode surfaces. Fe3O4 and RGO have been implied as new promising composite nanomaterials for immobilizing enzymes and efficient platforms due to their superparamagnetism properties. Thus, glucose EBCs could potentially be used as self-powered biosensors or electric power sources for biomedical device applications.

SUBMITTER: Pakapongpan S

PROVIDER: S-EPMC5635112 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Magnetic Nanoparticle-Reduced Graphene Oxide Nanocomposite as a Novel Bioelectrode for Mediatorless-Membraneless Glucose Enzymatic Biofuel Cells.

Pakapongpan Saithip S Tuantranont Adisorn A Poo-Arporn Rungtiva P RP

Scientific reports 20171010 1

In this work, an enzymatic biofuel cell (EBC) based on a membraneless and mediatorless glucose enzymatic fuel cell system was constructed for operation in physiological conditions (pH 7.0 and temperature 37 °C). The new platform EBC made of nanocomposite, including magnetic nanoparticles (Fe<sub>3</sub>O<sub>4</sub> NPs) and reduced graphene oxide (RGO), was used for the immobilization of glucose oxidase (GOD) as bioanode and bilirubin oxidase (BOD) as biocathode. The EBC bioelectrodes were fabr ...[more]

PMID: 29018210

Similar Datasets

Project description:Nanotechnology-based antioxidants and therapeutic agents are believed to be the next generation tools to face the ever-increasing cancer mortality rates. Graphene stands as a preferred nano-therapeutic template, due to the advanced properties and cellular interaction mechanisms. Nevertheless, majority of graphene-based composites suffer from hindered development as efficient cancer therapeutics. Recent nano-toxicology reviews and recommendations emphasize on the preliminary synthetic stages as a crucial element in driving successful applications results. In this study, we present an integrated, green, one-pot hybridization of target-suited raw materials into curcumin-capped gold nanoparticle-conjugated reduced graphene oxide (CAG) nanocomposite, as a prominent anti-oxidant and anti-cancer agent. Distinct from previous studies, the beneficial attributes of curcumin are employed to their fullest extent, such that they perform dual roles of being a natural reducing agent and possessing antioxidant anti-cancer functional moiety. The proposed novel green synthesis approach secured an enhanced structure with dispersed homogenous AuNPs (15.62 ± 4.04 nm) anchored on reduced graphene oxide (rGO) sheets, as evidenced by transmission electron microscopy, surpassing other traditional chemical reductants. On the other hand, safe, non-toxic CAG elevates biological activity and supports biocompatibility. Free radical DPPH inhibition assay revealed CAG antioxidant potential with IC50 (324.1 ± 1.8%) value reduced by half compared to that of traditional citrate-rGO-AuNP nanocomposite (612.1 ± 10.1%), which confirms the amplified multi-potent antioxidant activity. Human colon cancer cell lines (HT-29 and SW-948) showed concentration- and time-dependent cytotoxicity for CAG, as determined by optical microscopy images and WST-8 assay, with relatively low IC50 values (~100 ?g/ml), while preserving biocompatibility towards normal human colon (CCD-841) and liver cells (WRL-68), with high selectivity indices (? 2.0) at all tested time points. Collectively, our results demonstrate effective green synthesis of CAG nanocomposite, free of additional stabilizing agents, and its bioactivity as an antioxidant and selective anti-colon cancer agent.

Dataset Information

Magnetic Nanoparticle-Reduced Graphene Oxide Nanocomposite as a Novel Bioelectrode for Mediatorless-Membraneless Glucose Enzymatic Biofuel Cells.

Publications

Magnetic Nanoparticle-Reduced Graphene Oxide Nanocomposite as a Novel Bioelectrode for Mediatorless-Membraneless Glucose Enzymatic Biofuel Cells.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets